{
    "2021-03-08": [
        [
            {
                "time": "",
                "original_text": "医药行业一周观察：大小市值表现分化 关注二线优质公司的机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "市值表现",
                        "二线优质公司",
                        "机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "三家国内IVD械企净利润超20亿",
                "features": {
                    "keywords": [
                        "IVD",
                        "械企",
                        "净利润",
                        "20亿"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}